Search results
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 3 hours agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 20 hours agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 11 hours agoThe Covid effect not as damaging as feared For its first quarter, Pfizer reported before market open, the pharmaceutical giant took in just under $14.9...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 14 hours agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 12 hours agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 21 hours agoPfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year...
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 20 hours agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs ...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 10 hours agoI am pleased and appreciative of how our Pfizer colleagues are executing with discipline as they focus on the patients and others we serve. This helped...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 1 hour agoPfizer- $10.58 bn In the midst of the waning demand for Pfizer’s Covid-19 vaccine and antiviral Paxlovid (nirmatrelvir ...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 12 hours agoPfizer Chief Executive Albert Bourla said in an interview Wednesday he was encouraged but that the company's stock is undervalued.
